MYC and breast cancer: Furthermore, 9 out of 18 sets showed a statistically significant enrichment with the p-value < 0.05, including the MYC oncogenic signature genes derived from the DNA microarray analysis of the breast cancer cells (p = 0.040, FDR = 5.6%, normalized enrichment score, NES = 1.5) (Fig. 5).